Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.18 DKK | +2.85% |
|
-3.53% | -0.41% |
06-26 | Otsuka and Lundbeck's PTSD Treatment Moves Forward as FDA Accepts New Drug Application | MT |
06-25 | US FDA Accepts Lundbeck, Otsuka's New Drug Application for PTSD Combo Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.13% | 75.74B | |
-5.35% | 23.24B | |
+15.24% | 8.76B | |
-33.02% | 6.69B | |
+3.30% | 4.22B | |
-3.66% | 3.99B | |
+14.24% | 3.39B | |
+8.74% | 3.23B | |
-14.80% | 3.13B |
- Stock Market
- Equities
- HLUN B Stock
- LUN Stock
- News Lundbeck
- Transcript : H. Lundbeck A/S Presents at 35th Annual JP Morgan Healthcare Conference, Jan-09-2017 04